کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3090484 1190271 2006 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prise en charge thérapeutique de la démence à corps de Lewy
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
پیش نمایش صفحه اول مقاله
Prise en charge thérapeutique de la démence à corps de Lewy
چکیده انگلیسی
Dementia with Lewy bodies (DLB) is known for its partial resistance and hypersensitivity to some treatments, but DLB is treatable with cholinesterase inhibitors, sometimes better than in Alzheimer's disease. Cholinesterase inhibitors have a symptomatic effect on cognition and behavior. Nevertheless, new antipsychotics are sometimes also useful to manage psychotic symptoms. Although DLB patients respond less well to levodopa than patients with Parkinson's disease, 75 percent of DLB patients improve with levodopa, which is the best-tolerated dopaminergic agent. Nonpharmacological strategies include speech therapy, physiotherapy, psychotherapy, and educational support groups for care givers.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revue Neurologique - Volume 162, Issue 1, January 2006, Pages 131-136
نویسندگان
, ,